Last updated: February 1, 202618 min read

Key Takeaways

  • IV ketamine delivers 100% bioavailability -- the highest of any administration route -- making it the gold standard for ketamine therapy.
  • A typical IV ketamine protocol involves 6 infusions over 2-3 weeks at 0.5 mg/kg, with sessions lasting approximately 40 minutes.
  • Costs range from $400-$800 per infusion and are generally not covered by insurance, though some clinics offer package pricing.
  • Research shows 60-70% of patients with treatment-resistant depression respond to IV ketamine, often within hours of the first infusion.
  • IV infusions require medical supervision in a clinical setting with vital sign monitoring throughout the session.

IV Ketamine Infusion: The Gold Standard of Ketamine Therapy

Intravenous ketamine infusion has become one of the most significant developments in psychiatric treatment in decades. For patients who have tried multiple antidepressants without lasting relief, IV ketamine offers something remarkable: the possibility of feeling better within hours rather than weeks.

Since Yale researcher Dr. John Krystal first explored ketamine's antidepressant properties in the 1990s, IV infusion has accumulated the deepest evidence base of any ketamine delivery method. Today, hundreds of specialized clinics across the United States offer this treatment to patients with treatment-resistant depression, anxiety, PTSD, chronic pain, and other conditions.

This guide covers everything you need to know about IV ketamine infusions -- how the procedure works, what it costs, what the research shows, and what you can expect during and after treatment.

What Is IV Ketamine Infusion?

IV ketamine infusion involves delivering a sub-anesthetic dose of ketamine directly into the bloodstream through an intravenous line. Unlike oral or nasal forms of ketamine that must pass through the digestive system or nasal membranes, IV delivery provides 100% bioavailability -- meaning every milligram reaches the brain.

How It Differs from Other Ketamine Treatments

Ketamine was first approved by the FDA as an anesthetic in 1970. When used for mood disorders, it is administered at doses far below the anesthetic threshold. The IV route is considered the gold standard because:

  • Complete absorption: 100% of the medication reaches systemic circulation
  • Precise dosing: Clinicians can adjust the infusion rate in real time based on patient response
  • Most studied: The vast majority of ketamine depression research has used IV administration
  • Rapid onset: Effects begin within minutes as the drug enters the bloodstream directly
  • Predictable pharmacokinetics: The dose-response relationship is well characterized

The key mechanism involves NMDA receptor antagonism and a subsequent glutamate surge that promotes synaptic plasticity and the growth of new neural connections. This is fundamentally different from traditional antidepressants that target serotonin, norepinephrine, or dopamine. It is this unique mechanism that allows ketamine to work within hours rather than the weeks required by conventional medications.

How IV Ketamine Is Administered

Understanding the step-by-step process helps reduce anxiety about the procedure.

Before Your Appointment

  1. Initial consultation: A medical provider reviews your psychiatric history, current medications, and suitability for ketamine therapy
  2. Fasting: Most clinics recommend no food for 4-6 hours before the infusion (clear liquids usually permitted until 2 hours before)
  3. Medication review: Certain medications, particularly benzodiazepines and lamotrigine, may need to be adjusted as they can reduce ketamine's effectiveness
  4. Arrange transportation: You will not be able to drive for at least 12 hours after the infusion

During the Infusion

  1. Intake and vitals: A nurse or medical assistant records your blood pressure, heart rate, and oxygen saturation
  2. IV placement: A small catheter is inserted into a vein in your arm or hand
  3. Monitoring setup: Continuous pulse oximetry and periodic blood pressure measurements
  4. Infusion begins: Ketamine is delivered slowly over approximately 40 minutes at a dose of 0.5 mg/kg
  5. Observation: A clinician remains nearby throughout, adjusting the rate if needed
  6. Dissociative experience: Most patients experience altered perception, a floating sensation, or dreamlike states during the infusion
  7. Infusion ends: The IV is removed and you rest in a recovery area

After the Infusion

  1. Recovery period: 30-60 minutes of observation as effects wear off
  2. Post-infusion assessment: Brief check-in with clinical staff about your experience
  3. Discharge: Your designated driver takes you home
  4. Rest: Most providers recommend a quiet, relaxed evening after treatment

Dosing and Protocols

Standard Depression Protocol

The most widely used protocol for treatment-resistant depression:

  • Dose: 0.5 mg/kg of body weight
  • Duration: Infused over 40 minutes
  • Frequency: 6 infusions over 2-3 weeks (typically Monday-Wednesday-Friday or similar schedule)
  • Maintenance: After the initial series, booster infusions every 3-8 weeks as needed

Chronic Pain Protocol

Chronic pain conditions often require different dosing:

  • Dose: 0.5-1.0 mg/kg for standard sessions; multi-day infusions at higher doses for conditions like CRPS
  • Duration: Standard pain infusions last 4-6 hours; extended protocols may run over multiple days
  • Frequency: Series of 3-5 infusions initially, with maintenance as needed

Dose Adjustments

Experienced clinicians may adjust dosing based on:

  • Body weight: The mg/kg calculation is foundational
  • Response: Some patients benefit from slightly higher or lower doses
  • Tolerance: Over time, some patients may need modest dose increases
  • Side effects: If dissociation is distressing, the rate may be slowed

Conditions Treated with IV Ketamine

IV ketamine has demonstrated efficacy for multiple conditions:

  • Treatment-Resistant Depression: The most studied indication, with response rates of 60-70%
  • Anxiety Disorders: Generalized anxiety, social anxiety, and treatment-resistant anxiety
  • PTSD: Emerging evidence for trauma-related disorders
  • Chronic Pain: CRPS, neuropathic pain, fibromyalgia, and other chronic pain syndromes
  • OCD: Early research showing promise for obsessive-compulsive disorder
  • Bipolar Depression: Used cautiously with appropriate monitoring
  • Suicidal ideation: Rapid reduction in suicidal thoughts, a unique property among psychiatric treatments
IV Ketamine vs. Other Ketamine Treatments
FeatureIV InfusionIM InjectionSpravato (Nasal)Sublingual
Bioavailability100%~93%~48%~30%
Onset of action1-5 minutes5-15 minutes15-20 minutes15-30 minutes
Session duration~40 min infusion~30-45 min~2 hours total~45-90 min
Dose controlPrecise (real-time)Fixed once injectedFixed per deviceVariable absorption
FDA approved
Insurance coverageRarelyRarelyOften coveredRarely
Cost per session$400-$800$300-$600$500-$900$100-$300
SettingClinic onlyClinic onlyCertified facilityHome or clinic
Supervision requiredYes (full session)Yes (full session)Yes (2+ hours)Varies
Research depthExtensiveGrowingExtensive (Janssen)Moderate

Research Evidence

IV ketamine is the most extensively studied route of ketamine administration for psychiatric conditions. Key findings from landmark studies include:

Foundational Studies

Berman et al. (2000): The first controlled study demonstrating ketamine's antidepressant effects. Seven patients with major depression received a single 0.5 mg/kg IV ketamine infusion. Significant mood improvement was observed within hours, laying the groundwork for decades of subsequent research.

Zarate et al. (2006): This landmark randomized controlled trial at the National Institute of Mental Health showed that a single IV ketamine infusion produced rapid antidepressant effects in patients with treatment-resistant depression, with 71% of patients responding within 24 hours. Effects lasted up to one week in many patients.

Larger Trials

Murrough et al. (2013): A two-site randomized controlled trial compared IV ketamine to the active placebo midazolam in 73 patients with treatment-resistant depression. Response rate was 64% for ketamine versus 28% for midazolam at 24 hours post-infusion, providing robust evidence of ketamine's rapid antidepressant effect.

Singh et al. (2016): This study investigated repeated IV ketamine infusions (twice weekly for 2 weeks) and found that 67% of patients achieved response with the repeated dosing protocol, with benefits maintained through a subsequent observation period.

Chronic Pain Research

Sigtermans et al. (2009): In a randomized controlled trial for complex regional pain syndrome (CRPS), continuous IV ketamine infusion over 4 days produced significant pain relief lasting up to 3 months.

Schwenk et al. (2018): A systematic review of repeated ketamine infusions for chronic pain conditions found consistent evidence of analgesic effects, though optimal dosing protocols continue to be refined.

Safety and Long-Term Data

Fond et al. (2014): A meta-analysis of 9 studies confirmed the rapid antidepressant efficacy of ketamine with a standardized mean difference of 0.99 compared to placebo, establishing a strong overall effect size.

The American Psychiatric Association's 2017 consensus statement acknowledged ketamine's role as a promising treatment for mood disorders while calling for more long-term safety data and standardized protocols.

What to Expect During a Session

The Physical Experience

During the 40-minute infusion, you may experience:

  • Mild to moderate dissociation: A sense of detachment from your body or surroundings
  • Visual changes: Colors may appear brighter, and you may notice geometric patterns with eyes closed
  • Floating sensation: Many patients describe feeling weightless or as though they are floating
  • Altered time perception: The 40 minutes may feel shorter or longer than expected
  • Warmth or tingling: Some patients report sensations of warmth spreading through the body
  • Emotional processing: Some patients experience emotional memories or insights during the session

Common Side Effects

Most side effects are temporary and resolve within 1-2 hours after the infusion:

  • Nausea (often managed with pre-infusion anti-nausea medication)
  • Dizziness or lightheadedness
  • Elevated blood pressure (typically mild, monitored throughout)
  • Drowsiness
  • Mild headache
  • Blurred vision

Tips for a Positive Session

  • Bring comfortable clothing and a blanket or eye mask
  • Create a calming playlist -- many patients find music enhances the experience
  • Set an intention for the session (what you hope to process or work through)
  • Minimize stimulation -- dim lighting and a quiet environment help
  • Journal afterward to capture insights or reflections while they are fresh

Pros and Cons of IV Ketamine

Advantages

  • Highest bioavailability (100%): Every milligram reaches the bloodstream
  • Most studied route: Decades of clinical research supporting its efficacy
  • Precise dose control: Clinicians can adjust the infusion rate in real time
  • Rapid onset: Antidepressant effects can appear within hours
  • Effective for treatment-resistant conditions: Works through a novel mechanism (NMDA antagonism)
  • Rapid reduction of suicidal ideation: One of few treatments shown to quickly reduce suicidal thoughts

Limitations

  • Cost: $400-$800 per session, rarely covered by insurance
  • Requires clinic visits: Cannot be self-administered at home
  • IV access needed: Requires venipuncture, which some patients find uncomfortable
  • Time commitment: Including travel and monitoring, each session takes 2-3 hours
  • Temporary effects: Benefits typically require maintenance infusions every 3-8 weeks
  • Not FDA-approved for depression (used off-label; Spravato is the FDA-approved alternative)
  • Dissociative side effects: While generally mild, some patients find them distressing

Cost and Insurance

Typical Pricing

| Service | Cost Range | |---------|-----------| | Initial consultation | $150-$350 | | Single infusion | $400-$800 | | Initial series (6 infusions) | $2,400-$4,800 | | Maintenance infusion | $400-$800 each | | Annual maintenance (monthly) | $4,800-$9,600 |

Insurance Coverage

IV ketamine for psychiatric conditions is generally not covered by insurance because it is used off-label (the FDA has not specifically approved ketamine for depression). However:

  • Some insurers may cover the IV administration fee or monitoring costs
  • HSA/FSA funds can typically be used for ketamine infusions
  • Superbills: Many clinics provide documentation that patients can submit for potential partial reimbursement
  • Spravato alternative: If insurance coverage is essential, Spravato (esketamine) is FDA-approved and covered by many plans

Reducing Costs

  • Package pricing: Most clinics offer discounted rates for the 6-infusion series
  • Financing options: CareCredit, Prosper Healthcare Lending, and similar services
  • Clinic comparison: Prices vary significantly between clinics and regions
  • Ask about sliding scale: Some clinics offer reduced rates based on financial need

Finding a Provider

When searching for an IV ketamine clinic, look for:

Essential Qualifications

  • Board-certified physician (anesthesiologist, psychiatrist, or emergency medicine physician) overseeing treatment
  • Proper monitoring equipment: Pulse oximetry, blood pressure monitoring, emergency supplies
  • Established protocols: Written treatment guidelines, intake screening, and follow-up procedures
  • Dedicated treatment space: A comfortable, clinical environment designed for infusions

Red Flags

  • Clinics that guarantee results or make unrealistic claims
  • No physician involvement or oversight
  • No pre-treatment medical screening
  • Extremely low prices that suggest corners are being cut
  • Pressure to commit to large packages before trying a single session

Ready to find a qualified IV ketamine provider near you? Search our directory of vetted clinics to compare options in your area.

Is IV Ketamine Right for You?

IV ketamine infusion is typically recommended for patients who:

  • Have been diagnosed with treatment-resistant depression (failed 2 or more adequate antidepressant trials)
  • Experience chronic pain conditions that have not responded to conventional treatments
  • Are seeking rapid relief from severe depressive episodes or suicidal ideation
  • Are willing to commit to the time and cost of in-clinic treatment
  • Can arrange transportation to and from appointments

It may not be appropriate for patients with:

  • Active substance use disorders (particularly ketamine or PCP misuse)
  • Uncontrolled hypertension
  • Certain psychotic disorders
  • Pregnancy
  • Conditions that make IV access difficult

The first step is a comprehensive evaluation with a qualified provider. Find a ketamine clinic near you to schedule a consultation and determine whether IV ketamine infusion is the right treatment path for your situation.

Frequently Asked Questions About IV Infusion

References

  1. [1]A Randomized Trial of an N-Methyl-D-Aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry (2006)
  2. [2]Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression Biological Psychiatry (2013)
  3. [3]Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial American Journal of Psychiatry (2013)
  4. [4]Intravenous Ketamine for Treatment-Resistant Depression: A Pilot Study Biological Psychiatry (2000)
  5. [5]A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders JAMA Psychiatry (2017)
  6. [6]Efficacy and Safety of Ketamine vs Midazolam for Emergency Department Patients in Acute Suicidal Ideation JAMA Network Open (2021)
  7. [7]Repeated Ketamine Infusions for Chronic Pain: A Systematic Review Regional Anesthesia & Pain Medicine (2018)
  8. [8]The Efficacy and Safety of Low-Dose Ketamine Infusion for Major Depression Psychopharmacology (2016)
  9. [9]Ketamine for Depression: Where Do We Go from Here? Biological Psychiatry (2012)
  10. [10]Cost-Effectiveness of Intravenous Ketamine and Intranasal Esketamine for Treatment-Resistant Depression JAMA Network Open (2022)

Next Steps

Was this article helpful?

Medical Disclaimer: The information on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Ketamine therapy should only be administered by licensed medical professionals in appropriate clinical settings.